Repository logo
 
No Thumbnail Available
Publication

New iron(II) cyclopentadienyl derivative complexes: synthesis and antitumor activity against human leucemia cancer cells

Use this identifier to reference this record.
Name:Description:Size:Format: 
New iron(II).pdf1.16 MBAdobe PDF Download

Advisor(s)

Abstract(s)

A new family of "Fe-II(eta(5)-C5H5)" half sandwich compounds bearing a N-heteroaromatic ligand coordinated to the iron center by a nitrile functional group has been synthesized and fully characterized by NMR and UV-Vis spectroscopy. X-ray analysis of single crystal was achieved for complexes 1 and 3, which crystallized in the monoclinic P2(1)/c and monoclinic P2(1)/n space groups, respectively. Studies of interaction of these five new complexes with plasmid pBR322 DNA by atomic force microscopy showed very strong and different types of interaction. Antiproliferative tests were examined on human leukemia cancer cells (HL-60) using the MTT assay, and the IC50 values revealed excellent antiproliferative activity compared to cisplatin. (C) 2014 Elsevier B.V. All rights reserved.

Description

Keywords

Iron(II) Cyclopentadienyl Atomic Force Microscopy (AFM) Leukemia Cancer Cells Apoptosis

Citation

VALENTE, Andreia; [et al] – New Iron(II) Cyclopentadienyl derivative complexes: Synthesis and antitumor activity against human leucemia cancer cells. Journal of Organometallic Chemistry. ISSN: 0022-328X. Vol. 756 (2104), pp. 52-60

Research Projects

Organizational Units

Journal Issue

Publisher

Elsevier Science SA

CC License

Altmetrics